We also demonstrate that intestinal-specific deletion of Hdac3 protects against adiposity, suggesting HDAC3 may represent a potential therapeutic target in preventing obesity and related diseases. This evidence concerns the gene HDAC3 and obesity due to melanocortin 4 receptor deficiency.